Skip to main content

Growth Trap Risks

Updated Jun 24, 2026 at 2:35pm

Research Draft High 1,234 words

A growth trap is a stock whose price embeds high future-growth expectations that the business ultimately fails to deliver, so that even a "fine" company produces a poor investment as its valuation multiple de-rates. The core tension is that growth investing is not about buying good businesses — it is about buying businesses whose growth exceeds the growth already priced in. The trap is the gap between a compelling qualitative narrative (disruption, hyper-growth, a vast addressable market) and the dual empirical realities that (1) extraordinary growth rarely persists, and (2) when an expensively-priced grower disappoints, the market is unforgiving. It is the growth-side mirror image of the value trap.

How it forms (the mechanics)

A growth trap is the product of two multiplicative forces working in the wrong direction at once:

  • Earnings disappointment — actual growth comes in below the trajectory implied by the price.
  • Multiple de-rating (compression) — the market re-rates the multiple it is willing to pay for each dollar of earnings, because the high multiple was itself a bet on growth that no longer looks credible.

Because price ≈ earnings × multiple, a stock priced for perfection can fall sharply even when earnings still grow, if the multiple contracts faster. The canonical case is Cisco Systems after 2000: earnings kept rising for years, yet the multiple deteriorated and the stock never reclaimed its peak. Multiple compression "is no compliment" — a falling P/E reflects a downward reassessment of growth, risk, or return on capital, not a bargain appearing.

The behavioral engine underneath is naive extrapolation. Lakonishok, Shleifer & Vishny (1994) showed investors project recent performance too far forward; the growth implied by glamour-stock multiples "significantly overestimates actual future growth." When mean reversion arrives — as it almost always does — the expectations gap closes violently.

How the risk is assessed in practice

Practitioners screen for the fragility of the embedded expectation, not just "is it expensive":

  • Decompose the valuation. A reverse-DCF or "expectations-implied growth" exercise backs out the growth rate and duration the current price requires. If that rate exceeds what almost any company has historically sustained, the bar is set for disappointment.
  • Stress-test persistence. Ask how many years of >15–20% growth the price assumes, then compare to base rates (below). Long-duration assumptions are the most dangerous.
  • Watch the leading cracks — decelerating revenue growth, softening incremental margins, rising customer-acquisition cost, slowing net retention, and serial guidance cuts. These precede the multiple break.
  • Distinguish secular from cyclical/narrative growth. Demand a durable moat (switching costs, network effects, scale) rather than a TAM slide.
  • Position-level discipline. Growth managers tend to sell disappointers fast; GMO notes the replacement stock itself has a meaningful chance of being another trap, so churning between glamour names doesn't escape the regime.

Adoption, debate & evidence

The phenomenon is well documented and broadly accepted across the value-oriented academic and practitioner literature; it is contested mainly by growth managers who argue the rare compounders justify the average drag.

  • Growth rarely persists. Chan, Karceski & Lakonishok (Journal of Finance, 2003, "The Level and Persistence of Growth Rates") found essentially no persistence in long-term earnings growth beyond chance, that analyst (IBES) long-term forecasts are systematically too optimistic with low predictive power, and that valuation ratios poorly predict future growth. Verdad's Brian Chingono re-ran the test out-of-sample on U.S. stocks 1997–2022 and the finding held. This is the empirical foundation: the thing growth pricing relies on — sustained above-average growth — is not reliably identifiable in advance.
  • Glamour underperforms on average. LSV (1994) reported low book-to-market (glamour) stocks returned ~9.3% annually vs. ~19.8% for high book-to-market (value) over the post-formation years of their sample — a ~10.5% gap. Research Affiliates (Arnott et al., "Why Hold Expensive Slow-Growing Stocks?") reported that the "slow growth / expensive" (glamour) bucket trailed the broad market by ~2% per annum, compounded over a ~57-year span (data back to 1969).
  • Growth traps are worse than value traps. GMO's research (25-year horizon) found value traps underperformed their universe by ~9.5% annually while growth traps underperformed by ~13.0% — because "when growth disappoints, [the market is] merciless," reflecting the elevated starting expectations.

Honest framing. These are averages across baskets, not a claim that any individual high-growth stock is doomed — the long-run equity winners (a small minority) are growth names. The base rates describe the population an investor is drawing from, which is why the expensive + slow-actual-growth combination, not growth per se, is the documented loser. The figures above are point estimates from specific studies and samples; they vary by period, region, and how "glamour/trap" is defined, so treat them as directional rather than precise constants.

Strengths & limitations of the concept

The growth-trap lens is most useful precisely when sentiment is most euphoric — late in a thematic cycle when narratives are widely held and multiples are stretched (dot-com 2000, the 2020–2021 unprofitable-growth peak). Its #1 practical value is forcing the question "what growth is already in the price?" before underwriting more.

Its limitations and #1 misuse: treating all high multiples as traps. Multiple compression can be perfectly rational when it merely normalizes a temporary over-valuation of a still-great business, and a genuine compounder can stay "expensive" for a decade and still win. Selling every high-multiple grower to avoid traps guarantees missing the durable winners that drive index returns. The concept identifies an elevated conditional probability of poor returns, not a deterministic outcome — and it is backward-prone: a name only proves it was a trap after the de-rating. It also gives no precise timing; expensive things can get more expensive for years before reverting.

Sources

Dispute flag: underperformance magnitudes are sample/definition-dependent point estimates; growth advocates counter that the rare durable compounders justify the average basket drag. Treat all figures as directional.